Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ EPCR, Mouse, Unlabeled, Clone: JRK1535,

Catalog No. MABS1271MI Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
100 μg
Conjugate:
Unconjugated
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity Conjugate
MABS1271MI 100 μg Unconjugated
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. MABS1271MI Supplier MilliporeSigma™ Supplier No. MABS1271
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

Endothelial protein C receptor (UniProt Q9UNN8; also known as Activated protein C receptor, APC receptor, CD201, Endothelial cell protein C receptor) is encoded by the PROCR (also known as EPCR) gene (Gene ID 10544) in human. The coagulation cascade is an evolutionary conserved pathway in vertebrates that maintains vascular integrity. The procoagulant activity of the tssue factor (TF) pathway is counterbalanced by the protein C (PC) anticoagulant pathway to avoid intravascular thrombosis. EPCR is a CD1d–like immune receptor that binds the γ-carboxyl glutamic acid-rich (Gla) domain of PC and markedly improves PC activation in response to thrombin binding to endothelial cell-expressed thrombomodulin. EPCR also serves as the co-receptor for activated PC (aPC) in vascular protective signaling mediated by activation of PAR1. In addition, EPCR is found on hematopoietic, neuronal and epithelial progenitor populations, as well as among highly aggressive basal-like breast cancer subtypes. Endothelial overexpression of EPCR attenuates metastasis, presumably by dampening thrombin generation that supports metastatic tumor cell survival. EPCR-dependent PAR1 activation by aPC also stimulates breast cancer cell migration and prevents apoptosis of lung cancer cells. EPCR-selected populations of breast cancer cells grow as non-adherent spheroids and have high tumorigenicity when injected at low cell numbers. EPCR is initially produced with a signal peptide (a.a. 1-17), the removal of which yields the mature protein with a large extracellular region (a.a. 18-210), followed by a transmembrane domain (a.a. 211-231) and a short cytoplasmic tail (a.a. 232-238).
TRUSTED_SUSTAINABILITY

Specifications

Antigen EPCR
Applications Neutralization
Classification Monoclonal
Clone JRK1535
Concentration Please refer to lot specific datasheet.
Conjugate Unconjugated
Formulation Purified mouse monoclonal IgG1κ antibody in PBS without preservatives.
Gene PROCR, EPCR
Gene Accession No. Q9UNN8
Host Species Mouse
Immunogen Recombinant human EPCR extracellular domain.
Purification Method Protein G Purified
Quantity 100 μg
Regulatory Status RUO
Research Discipline Signaling
Primary or Secondary Primary
Gene ID (Entrez) NP_006395.2
Test Specificity Clone JRK1535 blocked activated protein C (APC) from binding cell surface EPCR by targeting a conformational epitope at the extracellular domain (Liaw, P.C., et al. (2001). J. Biol. Chem. 276(11):8364-8370).
Target Species Human
Content And Storage Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Form Purified
Isotype IgG1 κ
Show More Show Less

For Research Use Only. Not for use in diagnostic procedures.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.